Multisystem Inflammatory Syndrome in Children (MIS-C): The Facts
- MIS-C is an inflammatory disease appearing in children amid COVID-19
- Symptoms include fever, vomiting, rash, diarrhea, and abdominal pain
- If your child presents these symptoms, it’s important to immediately contact your pediatrician or visit the emergency room
- Experts say that most children will remain healthy during the outbreak, but encourages parents to be vigilant about possible symptoms
“2020 has been a roller coaster ride in terms of public health,” says Cini Thayil, a board certified Fellow of American College of Emergency Physicians, about COVID-19 impacting the medical field.
The ongoing coronavirus pandemic has disrupted cancer treatment and research across the world, and has forced medical teams to adjust to changing guidelines and considering new treatment options for patients. While older adults and immunocompromised individuals have been more at risk of contracting COVID-19, Thayil says a new outbreak-related disease has appeared in children called Multisystem Inflammatory Syndrome in Children (MIS-C).
“In April, clinicians in the United Kingdom noticed that some children without any previous health problems were developing a systemic inflammatory disease,” says Thayil. “The United States, particularly New York City, began to see it in early May. Children present with a fever and have other symptoms like cough or difficulty breathing, conjunctivitis, rash, diarrhea, abdominal pain, vomiting or confusion. They could also have low blood pressure and the syndrome would proceed to multiorgan involvement. This means that their heart, kidneys, skin, brain, gastrointestinal system were being affected.”
Children who have developed MISC-C have either previously had COVID-19 or recently infected. These symptoms are similar to other diseases such as Kawasaki’s syndrome (a disease of the blood vessels which affect children under the age of 5) and Toxic Shock Syndrome (infection affecting multiple organs in the body which causes it to shut down). In order to find out of your child has MIS-C, it’s important to contact your doctor as soon as symptoms appear.
Dr. Puvri Parikh shares tips on how to care for pediatric cancer patients amid COVID-19
What Is MIS-C?
The Center of Disease Control and Prevention (CDC) has defined MIS-C through three main points.
- Person 21 years old or younger presenting symptoms of MIS-C as well as evidence of inflammation, hospital visits, and two or more organs affected by disease
- There is no possible other diagnosis besides MIS-C
- The person has tested positive for either past or current COVID-19 infection or exposure within four weeks before symptoms appeared
How To Recognize Symptoms of MIS-C
According to Thayil, MIS-C presented itself in healthy patients, but pediatric cancer patients may be at risk of developing the infection too. For children undergoing chemotherapy, it’s important doctors monitor any infectious symptoms during treatment. Thayil says the main symptoms to look for include: a fever higher than 100.4 degrees, Loss of appetite caused by nausea, vomiting, abdominal pain, and diarrhea, difficulty breathing, rashes on the hands, feet, and mouth, red eyes, extreme fatigue, and problems urinating.
Dave Dubin, who has Lynch Syndrome, explains why children should go through genetic testing
While MIS-C has presented itself among children during COVID-19, Thayil assures the SurvivorNet community that these symptoms don’t immediately represent a diagnosis. However, in order to properly help treat the disease, it’s important to be open with your doctors about symptoms and be examined as soon as possible. An early diagnosis often paves the way for the best treatment options.
“It does not mean every child will develop it, and most children will remain healthy aside from the usual colds and stomach bugs, [but] it is important that we are informed, aware and on the lookout for MIS-C,” Thayil says. “As with COVID-19 in adults, early symptom awareness, examination, diagnosis and treatment can set a more decisive path for our children.”
Learn more about SurvivorNet's rigorous medical review process.
Cini Thayil is a board certified Fellow of American College of Emergency Physicians with extensive clinical experience in academic, tertiary and community hospital settings, as well as administrative development and medical education. Read More
Multisystem Inflammatory Syndrome in Children (MIS-C): The Facts
- MIS-C is an inflammatory disease appearing in children amid COVID-19
- Symptoms include fever, vomiting, rash, diarrhea, and abdominal pain
- If your child presents these symptoms, it’s important to immediately contact your pediatrician or visit the emergency room
- Experts say that most children will remain healthy during the outbreak, but encourages parents to be vigilant about possible symptoms
“2020 has been a roller coaster ride in terms of public health,” says
Cini Thayil, a board certified Fellow of American College of Emergency Physicians, about COVID-19 impacting the medical field.
The ongoing coronavirus pandemic has disrupted cancer treatment and research across the world, and has forced medical teams to adjust to changing guidelines and considering new treatment options for patients. While older adults and immunocompromised individuals have been more at risk of contracting COVID-19, Thayil says a new outbreak-related disease has appeared in children called Multisystem Inflammatory Syndrome in Children (MIS-C).
Read More “In April, clinicians in the United Kingdom noticed that some children without any previous health problems were developing a systemic inflammatory disease,” says Thayil. “The United States, particularly New York City, began to see it in early May. Children present with a fever and have other symptoms like cough or difficulty breathing, conjunctivitis, rash, diarrhea, abdominal pain, vomiting or confusion. They could also have low blood pressure and the syndrome would proceed to multiorgan involvement. This means that their heart, kidneys, skin, brain, gastrointestinal system were being affected.”
Children who have developed MISC-C have either previously had COVID-19 or recently infected. These symptoms are similar to other diseases such as Kawasaki’s syndrome (a disease of the blood vessels which affect children under the age of 5) and Toxic Shock Syndrome (infection affecting multiple organs in the body which causes it to shut down). In order to find out of your child has MIS-C, it’s important to contact your doctor as soon as symptoms appear.
Dr. Puvri Parikh shares tips on how to care for pediatric cancer patients amid COVID-19
What Is MIS-C?
The Center of Disease Control and Prevention (CDC) has defined MIS-C through three main points.
- Person 21 years old or younger presenting symptoms of MIS-C as well as evidence of inflammation, hospital visits, and two or more organs affected by disease
- There is no possible other diagnosis besides MIS-C
- The person has tested positive for either past or current COVID-19 infection or exposure within four weeks before symptoms appeared
How To Recognize Symptoms of MIS-C
According to Thayil, MIS-C presented itself in healthy patients, but pediatric cancer patients may be at risk of developing the infection too. For children undergoing chemotherapy, it’s important doctors monitor any infectious symptoms during treatment. Thayil says the main symptoms to look for include: a fever higher than 100.4 degrees, Loss of appetite caused by nausea, vomiting, abdominal pain, and diarrhea, difficulty breathing, rashes on the hands, feet, and mouth, red eyes, extreme fatigue, and problems urinating.
Dave Dubin, who has Lynch Syndrome, explains why children should go through genetic testing
While MIS-C has presented itself among children during COVID-19, Thayil assures the SurvivorNet community that these symptoms don’t immediately represent a diagnosis. However, in order to properly help treat the disease, it’s important to be open with your doctors about symptoms and be examined as soon as possible. An early diagnosis often paves the way for the best treatment options.
“It does not mean every child will develop it, and most children will remain healthy aside from the usual colds and stomach bugs, [but] it is important that we are informed, aware and on the lookout for MIS-C,” Thayil says. “As with COVID-19 in adults, early symptom awareness, examination, diagnosis and treatment can set a more decisive path for our children.”
Learn more about SurvivorNet's rigorous medical review process.
Cini Thayil is a board certified Fellow of American College of Emergency Physicians with extensive clinical experience in academic, tertiary and community hospital settings, as well as administrative development and medical education. Read More
